Table 1 Determinations by ELISA for each factor analyzed, with the range of values observed among positive samples, the number of positive samples in each group, and the detection limit of assays
ELISA targets | AT-Ex | Plasma | Detection limit | ||||
|---|---|---|---|---|---|---|---|
No. of positive samples | Mean ± SD | Range | No. of positive samples | Mean ± SD | Range | ||
bFGF | 20/20 | 4430.7 ± 3102.9 | 1015.5–11476.0 | 0/20 | ND | ND | 50 pg/ml |
EGF | 20/20 | 35.3 ± 21.0 | 15.5–63.1 | 20/20 | 562.5 ± 186.1 | 160.8–772.6 | 26 pg/ml |
Epo | 20/20 | 5.24 ± 1.87 | 2.26–8.6 | 20/20 | 7.83 ± 4.9 | 3.0–16.9 | 0.17 mlU/ml |
GM-CSF | 17/20 | 2.17 ± 1.38* | 01.6–4.4* | 20/20 | 10.2 ± 11.0 | 2.0–26.6 | 0.6 pg/ml |
KGF | 17/20 | 486.3 ± 279.5* | 176.4–1052.0* | 8/20 | 602.4 ± 612.6* | 150.0–1299.6 | 4.0 pg/ml |
SCF | 20/20 | 5.79 ± 2.82 | 1.6–10.4 | 0/20 | ND | ND | 0.45 ng/ml |
NGF | 20/20 | 95.2 ± 9.04 | 84.0–112.0 | 0/20 | ND | ND | 19.5 pg/ml |
VEGF-A | 20/20 | 2274.7 ± 964.7 | 315.8–2885.0 | 17/20 | 337.8 ± 243.3* | 0–775.3* | 7.9 pg/ml |
α-MSH | 20/20 | 2.16 ± 1.13 | 0.46–3.91 | 14/20 | 0.067 ± 0.043* | 0.029–0.146 | 0.039 ng/ml |
Wnt3a | 20/20 | 21.6 ± 2.4 | 9.82–28.0 | 4/20 | 0.50 ± 0.45* | 0.08 ± 1.25 | 0.054 ng/ml |
Wnt10b | 19/20 | 4.0 ± 1.26* | 0.24–4.25 | 0/20 | ND | ND | 0.058 ng/ml |